Nexovas TM 25 Tablet ER
Marketer
Macleods Pharmaceuticals Pvt Ltd
Salt Composition
Cilnidipine (10mg) + Metoprolol Succinate (23.75mg) + Telmisartan (40mg)
Overview Nexovas TM 25 Tablet ER
HyperTrol ER 25mg tablets combine medications to manage hypertension when monotherapy proves insufficient. This formulation lowers elevated blood pressure, mitigating the risk of future stroke and heart attack. HyperTrol ER 25mg can be ingested with or without food, at any time of day, but consistent daily timing is recommended. Continue treatment as directed by your physician; discontinuation, even with asymptomatic hypertension, may worsen the condition. Lifestyle modifications—including regular exercise, weight management, and a balanced diet—complement this therapy. Strictly adhere to your doctor's instructions. Potential side effects include nausea, altered taste, pharyngitis, back pain, and peripheral edema. Elevate your legs to reduce ankle swelling. Avoid potassium-rich foods and supplements. Regular monitoring of blood pressure, renal function, glucose levels, and electrolytes may be necessary. Prior to commencing treatment, disclose any liver or kidney impairment to your physician. Pregnant or lactating individuals should seek medical counsel before use. Inform your doctor about all other medications, particularly those for hypertension or cardiac conditions.
Uses of Nexovas TM 25 Tablet ER
Elevated blood pressure
Major Benefits of Nexovas TM 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Nexovas TM 25 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume this extended-release medication with a meal.
Common Side effects of Nexovas TM 25 Tablet ER:
- Nausea
- Taste change
- Diarrhea
- Headache
- Dizziness
- Weakness
- Ankle swelling
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Edema (swelling)
- Slow heart rate
- Cold extremities
- Decreased blood pressure
- Throat infection
How to use Nexovas TM 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Nexovas™ 25 Tablet ER. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.
How Nexovas TM 25 Tablet ER works:
Extended-release Nexovas 25mg tablets contain a triple-drug formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Nexovas TM 25 Tablet ER and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Nexovas TM 25 tablets pose a confirmed risk to a fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Medical advice is essential.
Breast feedingCONSULT YOUR DOCTOR
Data on Nexovas TM 25 Tablet ER use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Extended-release Nexovas 25mg tablets can induce drowsiness, visual disturbances, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Nexovas TM 25 Tablet ER use in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Nexovas TM 25 Tablet ER cautiously, potentially requiring dosage modification. Consult a physician. Nexovas TM 25 Tablet ER is contraindicated in those with severe liver disease.
What if you forget to take Nexovas TM 25 Tablet ER :
Should you forget a Nexovas TM 25 Tablet ER dose, take it immediately if you remember. But, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Nexovas TM 25 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |





